Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Advancing the ACR’s Legislative Priorities in 2021

Zach Wallace, MD, MSc  |  January 11, 2021

To state the obvious, 2020 was truly a year like no other. Our professional and personal lives were affected in ways none of us could have imagined. RheumPAC and ACR advocacy efforts were not spared the impacts of the pandemic.

In mid-March, we made the decision to halt RheumPAC solicitations because of the tremendous financial challenges we were all facing. I used to find solace in the profession of medicine, reminding myself that there will always be patients in need of medical providers. But this pandemic reminded us that none of us are immune to the impacts of a pandemic. In addition to worry over our own health and that of our families, providers across the spectrum of care (community practice, hospital-based, academic) faced grave financial strain and many were unsure how they would keep their doors open.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Although we halted solicitations, the work of RheumPAC and the ACR advocacy team did not lose steam. Leveraging the existing relationships that your RheumPAC contributions have helped cultivate over the years, we flexed our strength to remind Congress that rheumatology providers needed support for practices to stay open and deliver needed care for our patient population. We were pleased to see COVID-19 relief packages pass through Congress, and we anticipate additional support packages are on the horizon. We were also able to successfully advocate on behalf of our members who were suddenly thrust into the new world of telemedicine. Meanwhile, we continued to advocate for many of the priorities we had pre-COVID, including a historic win for an estimated average 14-15% increase in Medicare payments for evaluation and management services, reauthorization of the Pediatric Subspecialty Loan Repayment program, enactment of surprise billing legislation, and accruing more support for step therapy and prior authorization reform bills in the House and Senate.

Recognizing the key role of RheumPAC in facilitating our advocacy successes and the ever-increasing number of important policy discussions being had in Congress, we decided it was critical to resume fundraising in August. Adequate resources were needed to continue to educate legislators on the serious issues the rheumatology community has faced and will continue to face over the next year. We thank everyone who, despite the extraordinary circumstances, gave any amount this year to RheumPAC. I’m proud that, in the face of all that 2020 threw at us, we were still able to raise $121,250 from 286 individuals.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

With a vaccine now being deployed, 2021 is looking better, but we still have our work cut out for us on Capitol Hill, and RheumPAC will be a key component in getting our legislative priorities across the finish line in a new Congress. As a reminder, our mission is to educate, support and thank our key partners in Congress. Every single dollar raised goes directly to carefully chosen campaigns that maximize our reach. With so many new faces in Congress and different legislators in key leadership positions, it will be especially important that RheumPAC continue to build relationships with the offices of the many healthcare policy stakeholders.

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:legislation and advocacyRheumPACZachary Wallace

Related Articles

    The 2022 ARP President’s & Merit Awards

    November 6, 2022

    During ACR Convergence 2022 in early November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the recipients of the ARP President’s and Merit Awards. ARP PRESIDENT’S AWARDS The ARP president can choose to honor ACR/ARP…

    The 2021 ARP President’s Awards & Merit Awards

    November 14, 2021

    During ACR Convergence 2021 in early November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the winners of the ARP President’s and Merit Awards. ARP PRESIDENT’S AWARDS The ARP president can choose to honor ACR/ARP…

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

    The 2019 ARP Awards of Distinction & ACR Masters

    November 16, 2019

    ATLANTA—At the 2019 ACR/ARP Annual Meeting in November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARP Merit Awards about their individual contributions to advancing rheumatology. You’ll also find a…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences